About | Free Trial

Last Update

2016-06-24T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Donald Hayden?

Mr. Donald Hayden J. Jr.

Director

AMICUS THERAPEUTICS INC

HQ Phone: (609) 662-2000

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

AMICUS THERAPEUTICS INC

1 Cedar Brook Drive

Cranbury, New Jersey 08512

United States

Company Description

Amicus Therapeutics (Nasdaq: FOLD) is a biotechnology company at the forefront of therapies for rare and orphan diseases. The Company has a robust pipeline of advanced therapies for a broad range of human genetic diseases. Amicus’ lead programs in devel ... more

Find other employees at this company (258)

Background Information

Employment History

Chairman

Insmed Incorporated

Chairman

Vitae Pharmaceuticals , Inc.

Director

Otsuka Pharmaceutical Co. , Ltd.

Chairman

Azelon Pharmaceuticals Inc

Chairman

REGENXBIO Inc.

Key Executive Roles

Global Pharmaceutical Corporation

Director of New Business Development and Planning

USA Pharmaceutical Group

Affiliations

Senior Advisor
Prospect Venture Partners

Chairman
Transave , Inc.

Board Member
Alvine Pharmaceuticals Inc

Board Member
Dimension Therapeutics, Inc.

Board of Trustees Member
Cancer Care , Inc.

Executive Vice President and President, Americas
Bristol-Myers Squibb Company

Chairman
Gloucester Pharmaceuticals Inc

Board Member
Satori Pharmaceuticals Incorporated

Education

BA

Harvard University

Masters of Business Administration degree

Indiana University

undergraduate degree

Harvard University

Web References (182 Total References)


Board of Directors - Vitae Pharmaceuticals

vitaepharma.com [cached]

Donald Hayden, Jr. has served as a member of our board of directors since 2006 and the Chairman of the board of directors since 2006.

Mr. Hayden previously served as the Executive Chairman of Transave, a biotechnology company, from 2006 until 2010, when Transave was acquired by Insmed, a biotechnology company. From 1981 to 2006, Mr. Hayden was an executive with Bristol-Myers Squibb Company, where he served in key executive roles including President of Global Pharmaceuticals; Executive Vice President and President, Americas; Executive Vice President of the Health Care Group; President of Oncology and Immunology; and Senior Vice President of Worldwide Franchise Management and Business Development.
Mr. Hayden currently serves as lead independent director of Amicus Therapeutics Inc., a biopharmaceutical company, and as non-Executive Chairman of the board of directors of Insmed. Mr. Hayden is also a director of Otsuka America Pharmaceuticals, Inc., the U.S. subsidiary of Otsuka Pharmaceutical Company, Limited, a manufacturer of pharmaceuticals and nutraceutical products.
Mr. Hayden also serves on the boards of directors for four privately-held companies: Alvine Pharmaceuticals; Nora Therapeutics; ReGenX Biosciences; and Dimension Therapeutics. Mr. Hayden is also a senior advisor to Prospect Venture Partners, a venture capital firm.
Mr. Hayden holds a Bachelor of Arts degree in general studies from Harvard University and a Masters of Business Administration degree from Indiana University.
Mr. Hayden's qualifications to sit on our board include his extensive leadership, executive, managerial and business experience with life sciences companies, including experience in the formation, development and business strategy of multiple start-up companies in the life sciences sector.


Prospect Venture Partners :: Donald J. Hayden, Jr.

www.prospectventures.com [cached]

Donald J. Hayden, Jr.

...
Don Hayden is a Senior Advisor to Prospect Venture Partners. Mr. Hayden brings to Prospect the experiences and perspective resulting from a highly-successful 25 year career with Bristol-Myers Squibb Company as well as the insights gained from key roles at a number of smaller, more entrepreneurial pharmaceutical and biotech companies over the past 5 years. At Bristol-Myers Squibb, Mr. Hayden served as President of Global Pharmaceuticals; Executive Vice President and President, Americas, overseeing two major pharmaceutical units and two healthcare businesses; Executive Vice President of the Health Care Group; President of Oncology and Immunology; and Senior Vice President for Worldwide Franchise Management and Business Development. Since leaving Bristol-Myers Squibb in early 2006, Mr. Hayden has served as Chairman of Gloucester Pharmaceuticals, Vitae Pharmaceuticals, Insmed, and Azelon Pharmaceuticals, as Lead Director of Amicus Therapeutics, and as a Director of Otsuka Pharmaceuticals and Nora Therapeutics. Mr. Hayden received his undergraduate degree from Harvard University and has an M.B.A. from Indiana University.


Amicus Therapeutics

www.amicusrx.com [cached]

Donald J. Hayden , Jr. Lead Independent Director


Amicus Therapeutics

www.amicusrx.com [cached]

Donald J. Hayden , Jr. Lead Independent Director


Amicus Therapeutics

www.amicusrx.com [cached]

Donald J. Hayden , Jr. Amicus Therapeutics

...
Donald J. Hayden , Jr. Lead Independent Director
...
Donald J. Hayden , Jr. Lead Independent Director
From 1981-2006, Mr. Hayden had a highly-successful 25 year career in pharmaceuticals and related health care businesses with Bristol-Myers Squibb Company. Since March of 2006, Mr. Hayden has held key leadership roles at several venture-stage pharmaceutical and biotech companies.
At Bristol-Myers Squibb, Mr. Hayden served as executive vice president and president, Americas, overseeing two major pharmaceutical units and two healthcare businesses with combined annual sales in excess of $10 billion as well as global pharmaceutical manufacturing. Prior to that, Mr. Hayden held a number of senior management positions including vice president and general manager of Mead Johnson Laboratories; president of Oncology and Immunology; senior vice president for Worldwide Franchise Management and Business Development; president of Intercontinental and senior vice president, Business Development, Pharmaceuticals; president of Worldwide Medicines; executive vice president of Strategy; and executive vice president of the Health Care Group.
Since leaving Bristol-Myers Squibb in early 2006, Mr. Hayden has served as Chairman of Amicus Therapeutics, Transave Inhalation Biotherapeutics, Vitae Pharmaceuticals and Gloucester Pharmaceuticals as well as serving as a Director of Cogentus Pharmaceuticals.
Mr. Hayden received his undergraduate degree from Harvard University and has an M.B.A. from Indiana University.

Similar Profiles

Other People with this Name

Other people with the name Hayden

Karen Hayden
Holt Proctor McBriarty Insurance Agency Agency

Maya Hayden
Point Blue

David Hayden
African Americans

Caroline Hayden
McLaren Automotive Limited

William Hayden
Sky Alliance Resources

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory